UNSPSC 85891146: High dose rate (hdr) brachytherapy of brain using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of brain using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D01099Z

UNSPSC 85891146 High dose rate (HDR) brachytherapy of brain using iodine 125 (I-125) is a Commodity code, but the recent state and local solicitation activity under this code shows no alignment with the nominal scope. The County of Santa Clara Health System's solicitation RFSQHHSFY270052, posted July 7, 2026, explicitly establishes a qualified vendor pool for temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, orthopedics, respiratory care, sterile processing, and surgical operating room services — a scope unrelated to specialized brain brachytherapy procedures. This mismatch suggests either a classification error in how the opportunity was tagged or that the code does not see relevant procurement activity in the state and local market currently.

The single opportunity on record offers no decision-relevant data for vendors pursuing actual HDR brachytherapy services or related oncology radiation therapy offerings. The Santa Clara Health System RFQ, due October 7, 2026, targets temporary clinical staffing across multiple disciplines rather than equipment, devices, or specialized treatment services. No other recent state and local opportunities appear under this code. Practitioners in HDR brachytherapy, radiation oncology equipment, or related specialized clinical services should monitor whether issuing bodies begin tagging procurement correctly or seek this work through alternative UNSPSC classifications or cooperative purchasing vehicles targeting healthcare systems and oncology centers.